AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05594628 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neuromuscular training
Description: Neuromuscular training is designed as 8 weeks and 2 times a week, and approximately 20 minutes per session for Neuromuscular training+usual basketball training group. Other group is only going to keep attending usual basketball training.~Neuromuscular training consisted 3 exercises:~First exercise is passing the ball to side to side on bosu with standing on one leg. 60-90 seconds on time, 30-60 seconds off time. 2 sets for both passing sides and bilaterally.~Second exercise is standing on bosu unilaterally and while standing stabilized, switching basketball hand to hand as dribbling on the floor. Exercise will be on for 60-90 seconds and off for 30-60 seconds, 2 sets for each side Third exercise is jumping with one stance/leg, and landing with double stance while a therabant is attached to the belly and pulling with a minimum/medium force from one side. Changing legs after one jump, 6 times for both side is equal to 1 set of the exercise. It will be done 2 sets for both sides.
Study NCT04984668 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GT90001+KN046
Description: GT90001 4.5mg/Kg， KN046 3mg/Kg
Study NCT04984668 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GT90001+KN046
Description: GT90001 3mg/Kg ， KN046 3mg/Kg
Study NCT04563962 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contingency Management-ART
Description: Participants in this arm will participate in a Contingency Management intervention where rewards are linked with demonstrated adherence to tenofovir-based ART or PrEP.
Study NCT04563962 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Contingency Management-Methamphetamine
Description: Participants in this arm will participate in a Contingency Management intervention where rewards are linked with demonstrated abstinence from methamphetamine use.
Study NCT05118373 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: BEHAVIOURAL CHANGE CAMPAIGN FOR COVID-19 PREVENTION IN ZAMBIA
Description: The intervention is a mass media campaign using TV, radio, billboard and posters to disseminate the message. The content are well-produced videos and pictures emphasising the need to wash hands, wear a mask, maintain social distance and clean surfaces. The English version of the video can be viewed at this link: https://youtu.be/tcjaLAxy4Ms.
Study NCT06333366 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intra-gastrointestinal monitoring device (PDT)
Description: The PressureDOT(PDT) is an active intra-gastrointestinal device, that is intended to be introduced in the gastrointestinal tract, approximately along whole. The device is battery powered. The signal is wirelessly transmitted through outside the body and received by waist receiver, using an antenna array applied to the skin with a protection guard at the level of the abdomen.
Study NCT06400160 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TB511
Description: TB511 is a peptide drug conjugate (PDC) which composed of TAMpep826 peptide. TB511 is a white amorphous powder used for subcutaneous injections. TB511 is a peptide drug conjugate that combines a transporter peptide with a specific targeting of M2 macrophages and an apoptosis-inducing peptide (dKLA). As a transporter, the M2 binding peptide acts as a drug conjugate, explicitly binding to M2 macrophages and inducing cell penetration. In the cells, the dKLA component of TB511 binds to the mitochondrial membrane, destroys the mitochondrial membrane, and induces apoptosis by causing cytochrome release, leading to the destruction of the mitochondria and subsequent death of M2 macrophages.
Study NCT06400160 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Keytruda
Description: KEYTRUDA binds to the PD - 1 receptor, blocking both immune-suppressing ligands, PD L1 and PD L2, from interacting with PD - 1 to help restore T-cell response and immune response.
Study NCT05677373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BRD4 Inhibitor PLX2853
Description: Given PO
Study NCT05677373 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib
Description: Given PO
Study NCT05677373 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT with contrast
Study NCT05677373 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI with contrast
Study NCT05677373 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen collection
Description: Undergo collection of blood
Study NCT05677373 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen collection
Description: Correlative studies
Study NCT06079606 — intervention group
Intervention type: OTHER
Intervention: Antibiotic treatment
Description: Children will be assigned to groups according to antibiotic exposure in early life. No antibiotics will be given in the study.
Study NCT06235177 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Decompartmentalization Framework
Description: I will also be using mental imagery, consciousness, cognition, and cognitive psychology during this study to show the effectiveness of the conscious mind, and how the mind can influence behavior.~Decompartmentalize means to remove excessive compartmentalization; to restore from a compartmentalized state; to merge back together.
Study NCT06235177 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Liquid Herbal TInctures
Description: I will make and administer liquid herbal tinctures that will be made from all natural leafs, roots and flowers. I will focus on and track the participants' diagnosis, side effects, and how they feel before, during and after taking the liquid tincture.
Study NCT06235177 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mental Imagery
Description: I will have the participants focus on a particular shape, sound or image that they can see, think, or hear. This will allow the participant to have a clear mind, and release any negative thoughts, negative energy and boost their moods and their 5 senses.
Study NCT06235177 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Clinical Yoga
Description: I will show the participants many different yoga positions that will give them a peace of mind, stretch their muscles and release any tension throughout their body, and have an overall well-being, as well as promoting mindfulness.
Study NCT06235177 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary Supplements
Description: I will have the participants take an herbal supplement and/or vitamin that relates to the symptoms and current issues/diagnosis they have. The Dietary Supplements/Vitamins will enhance their capacity to overcome their health conditions, protect their body from unwanted germs and bacteria, and relieve the participants' mind and body from the symptoms they are experiencing based on their current condition.
Study NCT06235177 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Applied Relaxation
Description: Applied Relaxation is a specialized form of relaxation training that aims to teach the participant how to relax in common social situations.~Mindfulness training encourages participants to gain psychological distance from their worries and negative emotions, seeing them as an observer would see them. 2 types of mindfulness will be used, which is mindfulness-based stress reduction and mindfulness-based cognitive therapy. Treatment starts with general education about stress and social anxiety.
Study NCT06235177 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pain Relaxation Techniques
Description: Relaxation can reduce the feelings of stress, helping them to gain more control. Reduce pain by decreasing muscle tension, aches and pains. The body releases endorphins (the body's natural pain-killers) to relieve pain.~Yoga incorporates breath control, meditation, and gentle movements to stretch and strengthen muscles.~Mind-body techniques, which includes meditation, mindfulness, and breathing exercises help you restore a sense of control over your body and turn down the fight or flight response, which can worsen chronic muscle tension and pain.
Study NCT06235177 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Comprehensive Theocentric Psychological Assessment
Description: To enhance the lives of add to the lives of those who are well adjusted but know they have a greater potential within themselves to ring forth and live more fulfilling lives,
Study NCT05889780 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food pantry referrals
Description: Clients receive food for up to 21 meals per person in the household each month.
Study NCT05889780 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Food pantry referrals
Description: Clients receive food for up to 21 meals per person in the household each month.
Study NCT05889780 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No-prep, ready-to-eat meals
Description: 12 nutritious no-prep, ready-to-eat meals are provided each month.
Study NCT05889780 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vouchers
Description: A $75 voucher is provided each month and participants are instructed to use the voucher to purchase food or transportation to food retailers.
Study NCT05733208 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning
Description: Remote ischemic preconditioning will consist of four cycles of 5-minute inflation of an blood pressure cuff on the upper arm to 200 mmHg followed by 5-minute deflation. RIPC will be performed twice, one at approximately 24 hours before anaesthesia and the other at approximately 1 hour before anaesthesia.
Study NCT05733208 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham-remote ischemic preconditioning
Description: The identical looking cuff will be placed around the upper arm but not actually inflated for 40 minutes. The control device's components and external appearance are identical to that of the RIPC. However, as compared to the RIPC, the blood pressure cuff's line of inflation is disconnected such that the cuff cannot be inflated. Control treatment will be performed twice, one at approximately 24 hours before anaesthesia and the other at approximately 1 hour before anaesthesia.
Study NCT06234501 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Pyridoxal 5'-Phosphate (100 mg)
Description: 100 mg Pyridoxal 5'-Phosphate tablet once daily with food
Study NCT06234501 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo tablet once daily
Study NCT05843877 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Intraportal transplantation of isolated autologous pancreatic islets after total pancreatectomy
Description: Islet cells are isolated from patients healthy pancreatic tissue. Following total pancreatectomy, these autologous cells are injected into the portal vein, to implant in the liver and produce insulin.
Study NCT05843877 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Pancreaticoduodenectomy (classic Whipple or pylorus-preserving)
Description: As a standard procedure, the tumor-affected region of the pancreatic head with surrounding tissue and lymph nodes is removed during surgery. Reconstruction is performed by pancreaticojejunostomy.
Study NCT05617716 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Conventional external beam radiation therapy dose (EBRT)
Description: Participants will undergo 8 Gray in 1 fraction of EBRT
Study NCT05617716 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Spine radiosurgery/stereotactic body radiation therapy standard dose
Description: Participants will undergo 24 Gray in 2 fractions of SBRT
Study NCT05617716 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Spine radiosurgery/stereotactic body radiation therapy high dose
Description: Participants will undergo 19 Gray in 1 fraction of SBRT
Study NCT05805306 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Entre Herman@s
Description: The intervention unfolds as follows: (Week 1) the research team, Latino MSM, \& sibling will all engage in a PrEP Conversation followed by an individual Sibling Training for siblings to learn communication strategies for promoting health behaviors; (Week 2) we will send siblings reminders and a link to motivational interviewing techniques; (Week 3) we will conduct brief Follow-ups with siblings to determine if their brother changed his behavior; (Week 4) we will send a reminder to Latino MSM that they will have a follow-up the following week; (Week 5) we will conduct 30-day Follow-up with Latino MSM to determine if there was uptake of the new behavior change; (Week 7) same as week 5 above; (Week 10) send siblings information on motivational interviewing; (Week 12) final follow-up for both Latino MSM and siblings.
Study NCT05805306 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Vaccines for Health
Description: The intervention unfolds as follows: (Week 1) the research team, Latino MSM, \& sibling will all engage in a Health Conversation about vaccines for COVID, Hep A/B, or MPOX, followed by an individual Sibling Training for siblings to learn communication strategies for promoting health behaviors; (Week 2) we will send siblings reminders and a link to motivational interviewing techniques; (Week 3) we will conduct brief Follow-ups with siblings to determine if their brother changed his behavior; (Week 4) we will send a reminder to Latino MSM that they will have a follow-up the following week; (Week 5) we will conduct 30-day Follow-up with Latino MSM to determine if there was uptake of the new behavior change; (Week 7) same as week 5 above; (Week 10) send siblings information on motivational interviewing; (Week 12) final follow-up for both Latino MSM and siblings.
Study NCT05239390 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCI -110
Description: Dronabinol - Manufactured by Pharmaceutics International, Inc., Hunt Valley, MD 21031, USA. Dronabinol Capsules (dronabinol solution in sesame oil in soft gelatin capsules) are 2.5 mg - cream, oblong, soft-gel capsules. In an NDC 49884-867-02 Bottle of 60 capsules packaged in a well-closed container and stored in a locked refrigerator, 2° to 8°C. Protect from freezing, in accordance with the Israeli legal requirements (Israel Narcotic Drugs Act). Storage conditions should be monitored on a daily basis.~PEA - Manufactured by Pharmacies Inc. 767 Front st. Suite 202. Catasauqua, PA 18032 www.pharmacures.com. 1-888-334-3130. 400 mg PEA tablets, in a 60 mL barrier bottle, 30/400 mm, Bottle of 30 capsules packaged in a well-closed container and stored in RT (20° to 25°C). Storage conditions should be monitored on a daily basis.
Study NCT06417658 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic Supraorbital Eyebrow Craniotomy
Description: The Endoscopic Supraorbital Eyebrow Craniotomy is a minimally invasive neurosurgical procedure used to access and remove brain tumors located in the anterior skull base region. In this approach, surgeons make a small incision within the eyebrow area to gain access to the underlying pathology, avoiding larger incisions and more extensive tissue disruption associated with traditional open craniotomies.
Study NCT06417658 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Frontal Craniotomy
Description: The Conventional Frontal Craniotomy is a traditional surgical approach used to access and treat lesions located in the frontal region of the skull base. In this procedure, surgeons make a single or multiple large incisions in the scalp overlying the frontal bone to gain access to the underlying pathology.
Study NCT05775666 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: UCLM802 Cell Injection
Description: Anti-mesothelin CAR-T cells are autologous genetically modified T cells. A conditioning chemotherapy regimen of fludarabine and cyclophosphamide will be administered followed by UCLM802 cell injection.
Study NCT04823494 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hearing aids
Description: Earbud style hearing aids fit to both ears
Study NCT04657627 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PACE plus calorie labelling information
Description: The intervention group will be exposed to PACE plus calorie labelling information via Instagram and Twitter social media posts every day for 13 weeks.
Study NCT04657627 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Calorie-only labelling information
Description: The comparator group will be exposed to calorie-only labelling information via Instagram and Twitter social media posts every day for 13 weeks.
Study NCT05901766 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: UNIMAP Multiple Micronutrient Supplement
Description: Iodine Containing Multiple Micronutrient Supplement once daily
Study NCT06513481 — intervention group
Intervention type: DRUG
Intervention: Nardraparin calcium injection
Description: The dose of nardraparin calcium injection is 100AxaIU/kg, adjusted according to the patient's body weight, and is injected subcutaneously once a day
Study NCT06370611 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Early mobile health intervention supplemented by weekly calls from a physiotherapist
Description: Six-week home-based rehabilitation program using the ICURA app and sensor-based technology (ICURA ApS, Copenhagen, Denmark). During the hospital stay patients in the intervention group are introduced to the app's usage, and an individualized training plan is collaboratively created and subsequently tailored by a physiotherapist.~The comprehensive mobile health intervention includes customized training programs, activity tracking, visualization of exercises with videos, and a password-protected webpage for physiotherapists to customize training programs and track patient activity.~The patients will receive two calls from a physiotherapist per week for the first two weeks and as required the following four weeks.
Study NCT04793113 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FreshlyFit Meals
Description: FreshlyFit meals are low carbohydrate, high protein meals
Study NCT04422301 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood flow restriction
Description: an alternative method to produce strength and muscle hypertrophy with lower intensities
Study NCT06662747 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: None - observational study only
Description: No interventions, diagnostics tests for HIV, pregnancy, STIs and BV only
Study NCT06188949 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Dolichos biflorus (Horsegram) seed extract
Description: 1 capsule twice a day (Before breakfast \& dinner)
Study NCT06188949 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Carica papaya leaves extract
Description: 1 capsule twice a day (Before breakfast \& dinner)
Study NCT06188949 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (MCC)
Description: 1 capsule twice a day (Before breakfast \& dinner)
Study NCT05370300 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood test
Description: Proprietary immunogenomic signature from peripheral blood CD14 and CD2 cells.
Study NCT04794491 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JZP-258
Description: Maximum nightly dosage of 9 grams, administered once, twice or thrice nightly, with no single dose > 6 g
Study NCT04725864 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Progesterone vaginal tablet
Description: The study drug is progesterone 100 mg administrated as a vaginal tablet three times daily.
Study NCT06205875 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High dose serratus anterior plane block (2.4 mg/kg patient ideal body weight)
Description: The needle will be introduced in-plane from supero-anterior to postero-inferior until the needle tip is positioned in the plane underneath the serratus muscle (deep compartment). Under continuous ultrasound guidance, 3/4th of the bupivacaine 0.25% plus epinephrine solution will be injected in the deep compartment. After the deep component of the serratus anterior plane block is completed, the needle will be withdrawn to the subcutaneous tissues. The needle will be flattened and advanced in-plane to the plane superficial to the serratus muscles. The remainder quarter of the bupivacaine 0.25% plus epinephrine solution will be injected superficial to the serratus muscles after correct placement of the needle tip is confirmed on ultrasound. In total a dose of 2.4mg/kg patient ideal body weight will be administered. There is a maximal dose of 200 mg adrenalized bupivacaine for patients with an ideal body weight of 83 kg or more.
Study NCT06205875 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Low dose serratus anterior plane block (1.2mg/kg patient ideal body weight)
Description: The needle will be introduced in-plane from supero-anterior to postero-inferior until the needle tip is positioned in the plane underneath the serratus muscle (deep compartment). Under continuous ultrasound guidance, 3/4th of the bupivacaine 0.25% will be injected in the deep compartment. After the deep component of the serratus anterior plane block is completed, the needle will be withdrawn to the subcutaneous tissues. The needle will be flattened and advanced in-plane to the plane superficial to the serratus muscles. The remainder quarter of the bupivacaine 0.25% will be injected superficial to the serratus muscles after correct placement of the needle tip is confirmed on ultrasound.
Study NCT06205875 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: PCIA with morphine
Description: A patient controlled intravenous analgesia system (Bodyguard 595 Colorvision®) with morphine (Sterop®) using following settings: bolus 1.5 mg and lockout interval 7 min with maximal dose of 30mg per 4 hours.
Study NCT06205875 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PCIA with morphine
Description: A patient controlled intravenous analgesia system (Bodyguard 595 Colorvision®) with morphine (Sterop®) using following settings: bolus 1.5 mg and lockout interval 7 min with maximal dose of 30mg per 4 hours.